Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial

Clicks: 246
ID: 273607
2021
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #3 of 3 articles by views in blood cancer journal

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Although case-control analyses have suggested an additive value with the association of clarithromycin to continuous lenalidomide and dexamethasone (Rd), there are not phase III trials confirming these results. In this phase III trial, 286 patients with MM ineligible for ASCT received Rd with or wit …
Reference Key
n2021bloodlenalidomide Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Puig N;Hernández MT;Rosiñol L;González E;de Arriba F;Oriol A;González-Calle V;Escalante F;de la Rubia J;Gironella M;Ríos R;García-Sánchez R;Arguiñano JM;Alegre A;Martín J;Gutiérrez NC;Calasanz MJ;Martín ML;Couto MDC;Casanova M;Arnao M;Pérez-Persona E;Garzón S;González MS;Martín-Sánchez G;Ocio EM;Coleman M;Encinas C;Vale AM;Teruel AI;Cortés-Rodríguez M;Paiva B;Cedena MT;San-Miguel JF;Lahuerta JJ;Bladé J;Niesvizky R;Mateos MV;;
Journal blood cancer journal
Year 2021
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.